» Articles » PMID: 22847631

A New Link to Mitochondrial Impairment in Tauopathies

Overview
Journal Mol Neurobiol
Date 2012 Aug 1
PMID 22847631
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Tauopathies like the "frontotemporal dementia with Parkinsonism linked to chromosome 17" (FTDP-17) are characterized by an aberrant accumulation of intracellular neurofibrillary tangles composed of hyperphosphorylated tau. For FTDP-17, a pathogenic tau mutation P301L was identified. Impaired mitochondrial function including disturbed dynamics such as fission and fusion are most likely major pathomechanisms of most neurodegenerative diseases. However, very little is known if tau itself affects mitochondrial function and dynamics. We addressed this question using SY5Y cells stably overexpressing wild-type (wt) and P301L mutant tau. P301L overexpression resulted in a substantial complex I deficit accompanied by decreased ATP levels and increased susceptibility to oxidative stress. This was paralleled by pronounced changes in mitochondrial morphology, decreased fusion and fission rates accompanied by reduced expression of several fission and fusion factors like OPA-1 or DRP-1. In contrast, overexpression of wt tau exhibits protective effects on mitochondrial function and dynamics including enhanced complex I activity. Our findings clearly link tau bidirectional to mitochondrial function and dynamics, identifying a novel aspect of the physiological role of tau and the pathomechanism of tauopathies.

Citing Articles

Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism.

Richardson T, Hou X, Fiesel F, Wszolek Z, Dickson D, Springer W Acta Neuropathol Commun. 2025; 13(1):41.

PMID: 39994734 PMC: 11849217. DOI: 10.1186/s40478-025-01955-8.


Locus coeruleus vulnerability to tau hyperphosphorylation in a rat model.

Omoluabi T, Hasan Z, Piche J, Flynn A, Dore J, Walling S Aging Cell. 2024; 24(3):e14405.

PMID: 39520141 PMC: 11896524. DOI: 10.1111/acel.14405.


Cellular and pathological functions of tau.

Bravo C, Naguib S, Gan L Nat Rev Mol Cell Biol. 2024; 25(11):845-864.

PMID: 39014245 DOI: 10.1038/s41580-024-00753-9.


Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.

Isei M, Girardi P, Rodwell-Bullock J, Nehrke K, Johnson G J Neurochem. 2023; 168(6):1019-1029.

PMID: 37787052 PMC: 10987400. DOI: 10.1111/jnc.15975.


Genetically Engineered Triple -Mutant Human-Induced Pluripotent Stem Cells (N279K, P301L, and E10+16 Mutations) Exhibit Impairments in Mitochondrial Bioenergetics and Dynamics.

Szabo L, Grimm A, Garcia-Leon J, Verfaillie C, Eckert A Cells. 2023; 12(10).

PMID: 37408218 PMC: 10216799. DOI: 10.3390/cells12101385.


References
1.
Wang X, Su B, Fujioka H, Zhu X . Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol. 2008; 173(2):470-82. PMC: 2475784. DOI: 10.2353/ajpath.2008.071208. View

2.
Patterson G, Lippincott-Schwartz J . A photoactivatable GFP for selective photolabeling of proteins and cells. Science. 2002; 297(5588):1873-7. DOI: 10.1126/science.1074952. View

3.
Aleardi A, Benard G, Augereau O, Malgat M, Talbot J, Mazat J . Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr. 2005; 37(4):207-25. DOI: 10.1007/s10863-005-6631-3. View

4.
Jendrach M, Mai S, Pohl S, Voth M, Bereiter-Hahn J . Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion. 2008; 8(4):293-304. DOI: 10.1016/j.mito.2008.06.001. View

5.
Bunker J, Kamath K, Wilson L, Jordan M, Feinstein S . FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells. J Biol Chem. 2006; 281(17):11856-63. DOI: 10.1074/jbc.M509420200. View